chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Painful hot purple red arm from injection site to just above elbow and 50% of width of arm; Painful hot purple red arm from injection site to just above elbow and 50% of width of arm; Painful hot purple red arm from injection site to just above elbow and 50% of width of arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm), VACCINATION SITE ERYTHEMA (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: INFLUENZA since an unknown date.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm), VACCINATION SITE ERYTHEMA (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm). At the time of the report, VACCINATION SITE WARMTH (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm), VACCINATION SITE ERYTHEMA (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) and VACCINATION SITE PAIN (Painful hot purple red arm from injection site to just above elbow and 50% of width of arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant and treatment medications were provided.   This case was linked to MOD-2021-116330 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Folow-up added on 08-JUN-2021 contains no new information.
One day after injection noted to have 5 cm area of warm, red very tender area at upper deltoid along with 2 large finger like red streaks extending into left axillae. ROM limited to 70 degree extension. Tender to palpation. Treated with prednisone x 14 days.
R leg red, swollen medial to injections tp, injection site, superiorly and inferiorly at time if exam on 6-12-10, (R) leg is 2cm wider than (L) leg, knee swollen to occlude "dimples"  except for inferomedial. 16 cm x14cm is at site of affected area at longest and widest points. No induration at injection site. Sx peaked 7pm 6-11-10.
This spontaneous report was received from a pharmacist refers to a female patient of unknown age. No medical history was reported. On an unknown date in May 2013 (reported as a month ago), the patient was vaccinated with a dose of ZOSTAVAX (lot #, expiry not reported) and needs to have an epidural steroid injection for an unspecified reason on an unspecified date. No concomitant medications were reported. The outcome of the event was unknown. Additional information has been requested.
3 days after my first shot I got my first period in 9+ months, despite being on hormone therapy that should have prevented it. I have also since had another very heavy period, lots of clotting and cramping lasting 7+ days. No need for doctor care but wanted to report this anomaly for scientific purposes.
The patient reports severe muscle aches in the neck, arms, and hips that have been persistent since the injection and has not been able to conclude what else it could be from. He mentioned that it has been slowly getting better with time.
4/17 received VAR#2 imm. Redness at site that evening. Next day injection site was red (4"), swollen, painful, itchy, elbow was crampy. 4/22 saw doctor. Dr ordered Claritin for 8 days; Cephalexin 500mg TID x 10d. Took 2 weeks before redness and swelling resolved.
Patient developed hypotension x 1 day along with 2 day h/o myalgias, lightheadedness, subjective fever, and increased diarrhea.
No other issues or concerns noted; Improperly stored administered VARIVAX/Temperature excursion information: (-11.83C) for 2 hours and 30 minutes; This spontaneous report was received from other reporter, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided.  On 04-APR-2022, the patient was vaccinated with a dose of improperly stored (product storage error) varicella virus vaccine live (oka/merck) (VARIVAX) lot #: U016065, expiration date: 20-MAY-2023 (exact dose, strength, site and route of administration were not provided) for prophylaxis. Temperature excursion information: -11.83 degree Celsius for 2 hours and 30 minutes. No other issues or concerns noted (no adverse event).   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2204USA004055:
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy on or about 07-NOV-2013, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 12-OCT-2015, the patient was treated for a painful rash that was diagnosed as shingles, an incurable virus, for which the patient was prescribed gabapentin and valacyclovir (manufacturers unknown) to manage her symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Japanese encephalitis vaccine was administered on 10/8/02. The next day redness, swelling and itch wee noted at the injection site. No additional symptoms signs were reported. Itch and swelling has generally diminished.
p/vax pt devel fever to 102 x4-5day; lt post base of lung field w/bronchial; breath sounds like clinical pneumonia; tx: amoxicillin; hopefully will recover
PATIENT HAD NO ADVERSE REACTION TO AN UNQUALIFIED 3RD DOSE
After leaving pharmacy patient called reporting numbness on her neck, on the left side, radiating up to her lip and nose.  She stated feeling was not pain, but a numb sensation.  At the time no rash or itching was reported. Advised patient to go to emergency if swelling or difficulty breathing occurs. Explained that rash is a potential side effect so rash is not necessarily an indication of allergic reaction. Patient will monitor symptoms and go to emergency if condition worsens or if breathing is affected.
SORE ARM; This spontaneous report received from a consumer concerned a 72 year old male. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm. This report was non-serious.
Patient developed general malaise the night of adminstration, the following morning patient developed fever which was treated with ibuprofen. Patient continued to have fevers the next few days. On 4/18 he awoke with SOB and called ems. Fever was 103.6. Once in ER fever elevated to 106. reported fever/chills, fatigue/weakness, congestion/cough, SOA/dyspnea, wheezing, diaphoresis, body aches, and nausea post COVID-19 vaccination
pain in arm that evening.   Cold chills, numb fingers, tired, headache. Got shot Tuesday afternoon and Thursday morning woke up with a rash on my chest.
Papular rash (small itchy red spots) on all 4 extremities began 5/9 and continues today 5/18/22. Started on both thighs, spread down to the feet, then to both forearms, then to both upper arms. No rash on trunk or head. Treated with 1% hydrocortisone cream (no effect), Benadryl (no effect), Triamcinolone cream (no effect), aspiring (no effect). Cetirizine seems to be helping, though it may be just that enough time has gone by for the rash to begin subsiding.
Extreme fatigue, fever, and cold symptoms for 3 days. Then sinus symptoms and cold symptoms.  The Left Side of my head, face and next swelled up.  Both my glands and neck lymph nodes are swollen.  I was given antibiotics for a sinus infection on  10/7/22.  My swelling got worse so went in again on 10/10/22.  I missed work  9/29,/22, 9/30/22, 10/1/22 ,  Started feeling better the following week of 10/3/22, but as the week went  on felt worse.  I think that is why they thought a sinus infection.  Missed work again  10/8/22, 10/10/22, 10/11./22, and 10/12/22.  On Saturday 10/8/22 had severe pain in front forehead over eye, check, ear, and neck.  That is when the swelling got worse.  Medication did not help.  Was server Saturday and Sunday.  Then started getting better on Monday but swelling did not.
Approx 8 hours after immunizations given, vomiting 8-10 times. ER: emesis continued despite ZOFRAN - admit. Developed diarrhea. Mom now with similar symptoms.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/22/20 2nd dose01/13/21 Diagnosed covid positive:09/07/21 Symptom onset:09/05/21 Exposure:Travel Symptoms:cough, fatigue, sore throat, runny nose, HA.
Runny nose, Cough that progressed to wheezing. Received Flumist on Nov 10,2015 and then started to have symptoms within 24hrs with runny nose & cough. Wheezing started on Nov 13, 2015-Requiring Albuterol treatment. Patient recovered with treatment and close follow-up.
sore arm; Headache; possible spoiled vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm), HEADACHE (Headache) and EXPIRED PRODUCT ADMINISTERED (possible spoiled vaccine administered) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm), HEADACHE (Headache) and EXPIRED PRODUCT ADMINISTERED (possible spoiled vaccine administered). At the time of the report, MYALGIA (sore arm), HEADACHE (Headache) and EXPIRED PRODUCT ADMINISTERED (possible spoiled vaccine administered) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment details were provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-097962 (E2B Linked Report). This case was linked to MOD-2021-098020 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-097962:Case for patient
Information has been received from a nurse concerning a female patient who on approximately Dec 5, 2002 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot# 644105/0820M). in the right deltoid. Subsequently the patient developed symptoms of red, hot, painful to touch and swollen arm from elbow to shoulder. The nurse requested a lot check be performed on lot 644105/0820M. The nurse also reported another patient that developed a red, hot,painful to touch and swollen right arm from wrist to site of injection (WAES0212USA02343). Unspecified medical attention was sought. The records of testing to release of this lot has been checked by quality assurance and found to be satisfactory. The lot complies with the standards of the center for evaluation and research and was released. Additional information has been requested.
Loss of taste, body ache, general malaise, headache, tachycardia.
I noticed thick red rings around my armpits the night of the vaccination. Then, two days laters a rash on my torso spreading up to my shoulders around to my back.   I don?t recall ever having a reaction to a vaccine like this. However, I do know when my body is in the last stage of  fighting a virus, it breaks out in a rash often reaching from my shoulders down to my thighs. That said, I?ve never seen the thick rings surrounding my armpits even when fighting a virus.
Received shot at lunchtime.  Normal flu like symptoms late evening.  Started feeling tired & out of breath at work next day.   Pulse rate went up to 130+ and felt like I was going to pass out.    Went home to bed.  4 hours later took husband's beta blocker - pulse rate went down almost immediately.  Felt ok next day.  Just very tired.  -- VERY concerned about getting booster shot.
Initial misuse report received from a healthcare professional on 07 January 2014.  A 12-month-old male patient had received 0.25 ml of FLUZONE first dose on 11 November 2013 and second dose on 17 October 2013 and the patient had also received 0.5 ml third dose on an unspecified date. No adverse event was reported. List of documents held by sender: none.
Joint pain and mild headache for 24 hours, sore arm for about 3 days, fatigue and autoimmune flare for about 10 days
Patient developed red, hot, spots around the injection site of the left arm after one week of receiving Moderna Vaccine.
Pt reported flu like symptoms, chills, dizziness, nausea, headache and back ache within 4 hours of receiving the vaccination.  Pt called pharmacy and was told to get some tylenol for the bach aches and the headache.  Pt called the pharmacy the second time and was told to contact her physician.  Pt did go to ER the night of the vaccination for the symptoms previously reported.
Approximately 3 weeks post ZOSTAVAX, developed 8 lesions, dime sized, left upper arm. A couple of weeks later, developed sever, debilitating knee and hip pain and back muscle pain. Used OTC cortisone for lesions. Did not seek medical care.
tenderness...then turned pink the next day about 3 1/2 inches x 2 inch oval   Was gone by Sunday 3/7/2021. and the pink area starting with itchiness appeared on 3/12/2021..Itchiness stopped after applying topical Benadryl but the area is still pink.
I felt pain in my left arm beginning at 9:00 PM on the night I received the vaccine (01/18/2021).  At the time of this writing, my pain has not disappeared but is reducing as anticipated.  Throughout the day of 01/19/2021, I experienced symptoms of a mild fever and proceeded to nap at 5:15 PM.  At 7:30 PM, I was experiencing body chills and felt more defined effects of the fever.  I proceeded to take two Acetaminophen pills by 8:00 PM and my symptoms subsided later into the night.  At the time of this writing, I am only experiencing light headaches (I think) and reduced arm pain.  I believe my fever/body chill symptoms are no longer affecting me.
auras (wiggly lines and severely blurred vision) pounding headache, similar to a migraine, that is worse with movement body aches and fatigue nausea that is worsened with smells of food
pt recv vax 26APR fever, chills, h/a, cont w/sweating & low energy level;
Pt rec'd PNEUMOVAX 23 IM; c/o SOB, syncope, muscle weakness; O2 applied and 25mg Diphenhydramine IM administered.
ached all over, sharp pain shooting up the right side of my neck all the way to my ear, ran a fever that night, chills. Flu like symptoms for 2 days on both shots.
Dizziness & NauseaVomiting Narrative:  Employee reported dizziness that persisted for 45 minutes, incident occurred 17 hours following injection. Employee further reports that she did not eat breakfast and situation that precipitated event was bending over and standing upright quickly while assisting a patient. Employee has since fully recovered.
4:15 pm Client reported feeling warm on the face and headache after getting the vaccine while in 15 min observation. V/S: BP- 124/80, HR 83/min, O2 saturation 98%,  and Temp of 99.5 Client A/O, lung sounds clear on auscultation. No respiratory distress noted, no other symptoms observed.  4:40 pm Client released home with cousin, client reported symptoms fully resolved.
Warm sensation in my right arm and right ear, fingertips were tingling and numb feeling. Spoke with Dr and everything was fine.
Hypoxemia with sats of 84%, severe pain, nausea, weakness, fatigue, cough
This spontaneous case, initially received on 13-Jun-2018 was reported by other non-health professional and concerns a female patient of unspecified age. On an unspecified date, the patient was administered with influenza vaccine, (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacture: not reported). On an unspecified date after the administration of vaccine, the patient experienced mild rash, redness and warm feeling in the arm. At the time of this report, the outcome of the events was not reported. This case is linked to 201802363 due to same patient.
Vaccine administered 14 days from dose number 1. Observed patient for 30 minutes.  No adverse reactions.  Patient was accompanied by mother.  Mother scheduled the appointment online.  States she did not check the date on the back of the COVID vaccination record.  RN did not check the date on the back of record or count the interval before administration. Health Services Manager notified. Pfizer was notified via telephone call. Pfizer sent email stating studies indicate the dose should be repeated in 21 days.  This information was relayed to patients mother.
Side Effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side Effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side Effect). At the time of the report, VACCINATION COMPLICATION (Side Effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment information was provided.
reactive airway issue; asthma attack feeling; Initial information received on 05-Mar-2020 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a female patient who experienced reactive airway issue (bronchial hyperreactivity) and asthma attack feeling (dyspnoea), while she received vaccines INFLUENZA VACCINE [INFLUENZA VACCINE] and PNEUMOCOCCAL VACCINE POLYSACCH 23V (PNEUMOVAX 23).  Medical history, medical treatment, vaccination and family history were not provided.  On 11-Oct-2019, the patient received a dose of suspect INFLUENZA VACCINE and on 02-Mar-2020, the patient also received a dose of suspect PNEUMOCOCCAL VACCINE POLYSACCH 23V (PNEUMOVAX 23) not produced by Sanofi Pasteur (lot number and expiration date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious reactive airway issue (bronchial hyperreactivity) and asthma attack feeling (dyspnoea) a day or two day later following the administration of INFLUENZA VACCINE and PNEUMOCOCCAL VACCINE POLYSACCH 23V (PNEUMOVAX 23).  Details of laboratory data was not provided.  Final diagnosis was bronchial hyperreactivity and dyspnoea.   On an unknown date, the patient was treated with inhalers for dyspnoea and bronchial hyperreactivity.  The patient had recovered from bronchial hyper reactivity and dyspnoea.  Information on batch number was requested.
devel pruritis of scalp, hands, eyelids;no hives observed;DPH given;
TONGUE SWELL, BODY ITCH ALL OVER, (ears, mouth, eyes, feet, hands, all over)
A non-serious, spontaneous report of headache has been received from a consumer concerning an adult male subsequent to H1N1, Intranasal. Neither medical history nor concomitant medications were reported. The patient received H1N1, Intranasal on 13-Oct-2009 at 5 pm. On 13-Oct-2009 around 9 pm the patient experienced a headache lasting approximately one-half hour. The patient recovered from the event of headache on 13-Oct-2009.
At approximately 1100 patient reported to EMT that she felt dizzy 5 minutes after her vaccination. Patient did not report her dizziness when it first started. Patient moved to gravity chair and given water and juice. Patient denied itchiness, rashes, and hives. At 1104 EMT  assessed patient vitals: blood pressure 110/68 mmHg and pulse 99 beats/minute. Patient advised to wait for further observation. At 1115, EMT  reassessed patient vitals: blood pressure 126/76 mmHg and pulse 84 beats/minute. At 1130 EMT  reassessed patient vitals: blood pressure 140/96 mmHg and pulse 95 beats/minute. Patient reported no dizziness. RN educated patient on signs/symptoms of when to seek emergency care, to sign up on v-safe, and to follow up with primary care provider. At 1132, patient left facility with unlabored respirations and steady gait.
Rash; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Information has been received from a health professional concerning a patient (10 out of 40) who was vaccinated with Pneumovax 23 (lot number 651406/0620F).  It is unknown if the patient was vaccinated with the influenza virus vaccine (unspecified) on the same day.  Subsequently the patient experienced fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  Subsequently, the patient recovered from fever, pain at injection site, redness at injection site, swelling at injection site and red streaks on injection arm.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot complies with the standards of the agency and was released.  Additional information has been requested.
Severe left shoulder pain within hrs of vaccination. Pain initially # 10 with radiation up to neck and down to elbow. Pain was deep since mid Jan has dec to # 4. Problems with lifting overhead. Pain worse after activity and is interfering with sleep. No local site reaction. Never had problems with previous immunizations. She was sitting, vaccinator was standing. She thinks it may have been administered too high.   Symptoms: PAIN IN UNSPECIFIED JOINT(M2550), MYALGIA(M791).
Mom stated pt cried w/a high pitch cry for 24hrs; Only stopping after 10-15min; No local rxn or fever;
Shaking chills overnight - 8 hour duration - resolved on own Nausea overnight - 8 hour duration, resolved on own Mild headache - 24 hour duration - resolved with ibuprofen